Wesley Kaupinen is President and Chief Executive Officer of Palvella Therapeutics, Inc. (PVLA). The company reported total compensation of $3,404,904 for fiscal year 2025.
| Salary | $575,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $2,469,886 |
| Non-equity incentive plan | $359,375 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $643 |
| Total | $3,404,904 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Palvella Therapeutics, Inc. filed April 30, 2026, accession 0001104659-26-052875.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Wesley Kaupinen this page | President and Chief Executive Officer | $3,404,904 |
| Kathleen Goin | Chief Operating Officer | $1,979,837 |
| Matthew Korenberg | Chief Financial Officer | $1,971,437 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Palvella Therapeutics, Inc. compensation brief.
Wesley Kaupinen's compensation sits inside Palvella Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.